Benutzer: Gast  Login
Titel:

FCR front-line therapy and quality of life in patients with chronic lymphocytic leukemia.

Dokumenttyp:
Clinical Trial, Phase III; Journal Article; Multicenter Study; Article
Autor(en):
Kutsch, Nadine; Busch, Raymonde; Bahlo, Jasmin; Mayer, Jiri; Hensel, Manfred; Hopfinger, Georg; Hess, Georg; von Grünhagen, Ulrich; Wendtner, Clemens-Martin; Maria Fink, Anna; Fischer, Kirsten; Hallek, Michael; Eichhorst, Barbara
Abstract:
The chemoimmunotherapy FCR (fludarabine and cyclophosphamide with rituximab) is the standard first-line treatment for physically fit chronic lymphocytic leukemia (CLL) patients. To assess the risks and benefits, we investigated health-related quality of life (HRQOL). 817 untreated CLL patients received either FC or FCR within the GCLLSG CLL8 trial. The European Organization for Research and Treatment of Cancer Quality of life Questionnaire C30 was sent to all patients at baseline, after 3, 6, an...     »
Zeitschriftentitel:
Leuk Lymphoma
Jahr:
2017
Band / Volume:
58
Heft / Issue:
2
Seitenangaben Beitrag:
399-407
Sprache:
eng
Volltext / DOI:
doi:10.1080/10428194.2016.1190966
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/27357445
Print-ISSN:
1042-8194
TUM Einrichtung:
Institut für Medizinische Statistik und Epidemiologie
 BibTeX